1 Russell, W. M. S., and Burch, R. L. (1959). The Principles of Humane Experimental Techniques. Methuen, London, UK.

2 Milstein, J., Grachev, V., Padilla, A., and Griffiths, E. (1996). WHO activities towards the three Rs in the development and control of biological medicines. Dev. Biol. Stand. 86, 31-39.

3 Hartung, T. (2001). Three Rs potential in the development and quality control of pharmaceuticals. ALTEX 18, 3-11.

4 Chesne, C., Guyomard, C., Fautrel, A., Poullain, M. G., Fremond, B., De Jong, H., and Guillouzo, A. (1993). Viability and function in primary culture of adult hepatocytes from various animal species and human beings after cryopreservation. Hepatology 18, 406-414.

5 Day, J. G. and Stacey, G. N. (Eds.), Cryopreservation and Freezedrying Methods. Humana Press, Totowa, USA (in press).

6 Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A. J., Prieto, P., Sabbioni, E., Scott, L., Worth, A., and Zuang V. A. (2004). Modular approach to the ECVAM principles on test validity. Altern. Lab. Anim. 32, 467-472.

7 Stacey, G. N. (2002). Standardisation of cell lines. Dev. Biol. 111, 259-272.

8 MacLeod, R. A. F., Dirks, W. G., Matsuo, Y., Kaufman, M., Milch, H., and Drexler, H. G. (1999). Widespread intra-species cross-contamination of human tumour cell lines arising at source. Int. J. Cancer 83, 555-563.

9 Masters, J. R. W., Thompson, J., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P. I., Toji, L. H., Ohno, T., Tanabe, T. H., Arlett, C. F., Kelland, L. R., Harrison, M., Virmani, A., Ward, T. H., Ayres, K. L., and Debenham, P. G. (2001). Short tandem repeat profiling provides international reference standards for human cell lines. Proc. Natl. Acad. Sci. USA 98, 8012-8017.

10 Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Shechtman, L., Stacey, G., and Stokes, W. (2005). Guidance on Good cell culture practice: a report of the second ECVAM task force on good cell culture practice. Altern. Lab. Anim. 33, 261-287.

11 Stacey, G. N., Doyle, A., and Tyrrell, D. (1998). Source materials. In: Stacey, G. N., Doyle, A., and Hambleton, P. (Eds.), Safety in Cell and Tissue Culture. Kluwer Academic Publishers, Dordrecht, Netherlands, pp. 1-25.

12 Anderson, R., O'Hare, M., Balls, M., Brady, M., Brahams, D., Burt, A., Chesne, C., Combes, R., Dennison, A., Garthoff, B., Hawksworth, G., Kalter, E., Lechat, A., Mayer, D., Rogiers, V., Sladowski, D., Southee, J., Trafford, J., van der Valk, J., and van Zeller, A.-M. (1998). The Availability of Human Tissue for Biomedical Research - The Report and Recommendations of ECVAM Workshop. Altern. Lab. Anim. 26, 763-777.

13 Hartung, T., Balls, M., Bardouille, C., Blanck, O., Coecke, S., Gstraunthaler, G., and Lewis, D. (2002). Report of ECVAM task force on good cell culture practice (GCCP). Altern. Lab. Anim. 30, 407-414.

14 Coriell, L. L. (1984). Establishing and characterizing cells in culture. In: Acton, R. T. and Lynn, J. D. (Eds.), Eukaryotic Cell Cultures. Plenum Press, New York, pp. 1-31.

15 Freshney, R. I. (1990). Charakterisierung von Zellinien. In: Tierische Zellkulturen. Walter de Gruyter, Berlin, pp. 171-187.

16 Freshney, R. I. (1990). Induktion der Differenzierung. In: Tierische Zellkulturen. Walter de Gruyter, Berlin, pp. 188-197.

17 Harris, M. (1989). Phenotypic changes in cell cultures. Dev. Biol. (New York) 6, 79-85.

18 Hill, D. J. (1989). Cell multiplication and differentiation. Acta Paediatr. Scand. [Suppl.] 349, 13-20.

19 Oshima, J. and Campisi, J. (1991). Symposium: mammary cell proliferation and morphogenesis. J. Dairy Sci. 74, 2778-2787.

20 Watt, F. M. (1991). Cell culture models of differentiation. FASEB J. 5, 287-294.

21 The Standard Metabolic Reporting Structures Working Group (2005) Summary recommendations for standardisation and reporting of metabolic analyses. Nat. Biotechnol. 23, 833-838.

22 Rottem, S. and Naot, Y. (1998). Subversion and exploitation of host cells by Mycoplasma. Trends Microbiol. 6, 436-440.

23 Polyanskaia, G. G. and Samokisch, V. A. (1999). The study of quantitative karyotypic variability by induction of chromosomal instability in cultured cells of the Indian muntjac skin fibroblasts. Tsitologiia 41, 752-757.

24 Zurita-Salinas, C. S., Palacios-Boix, A., Yanez, A., Gonzalez, F., and Alcocer-Varela, J. (1996) Contamination with Mycoplasma spp. induces interleukin-13 expression by human skin fibroblasts in culture. FEMS Immunol. Med. Microbiol. 15, 123-128.

25 Fabisiak, J. P., Weiss, R. D., Powell, G. A., and Dauber, J. H. (1993). Enhanced secretion of immune-modulating cytokines by human lung fibroblasts during in vitro infection with Mycoplasma fermentans. Am. J. Respir. Cell Mol. Biol. 18, 358-364.

26 Boyle, J. M., Hopkins, J., Fox, M., Allen, T. D., and Leach, R. H. (1981). Interference in hybrid clone selection caused by Mycoplasma hyorhinis infection. Exp. Cell Res. 132, 67-72.

27 Mahy, B. W., Dykewicz, C., Fischer-Hoch S., et al., (1991). Virus zoonoeses and their potential for contamination of cell cultures. Dev. Biol. Stand. 75, 183-189.

28 Jones, N. and Lloyd, G. (1984). Infection of laboratory workers with hantavirus acquired from immunocytomas propagated in laboratory rats. J. Infect. 12, 117-125.

29 Frommer, W., Archer, L., Boon, B., Brunuis, G., Collins, C. H., Crooy, P., et al., (1993). Safe Biotechnology (5). Recommendations for safe work with animal and human cell cultures concerning potential human pathogens. Appl. Microbiol. Biotechnol. 39, 141-147.

30 Stacey, G. N. Risk assessment for cell culture processes. In: Stacey, G. N. and Davis, D. (Eds.), Medicines from Animal Cells. Wiley, Chichester, UK (in press).

31 Balls, M., Blaauboer, B., Brusick, D., Frazier, J., Lamb, D., Pemberton, M., Reinhardt, C., Roberfroid, M., Rosenkranz, H., Schmid, B., Spielmann, H., Stammati, A. L., and Walum, E. (1990). Report and recommendations of the CAAT/ERGATT workshop on validation of toxicity test procedures. Altern. Lab. Anim. 18, 303-337.

32 Balls, M., Blaauboer, B. J., Fentem, J. H., Bruner, L., Combes, R. D., Ekwall, B., Fielder, R. J., Guillouzo, A., Lewis, R. W., Lovell, D. P., Reinhardt, C. A., Repetto, G., Sladowski, D., Spielmann, H., and Zucco, F. (1995). Practical aspects of the validation of toxicity test procedures.

The report and recommendations of ECVAM workshop 5. Altern. Lab. Anim. 23, 129-147.

33 Curren, R. D., Southee, J. A., Spielmann, H., Liebsch, M., Fentem, J. H., and Balls, M. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. Altern. Lab. Anim. 23, 211-217.

34 Worth, A. P. and Balls, M. (2001). The role of ECVAM in promoting the regulatory acceptance of alternative methods in the European Union. Altern. Lab. Anim. 29, 525-536.

35 Balls, M. and Karcher, W. (1995). The validation of alternative methods. Altern. Lab. Anim. 23, 884-886.

36 Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Janusch Roi, A., Prieto, P., Sabbioni, E., Worth, A., and Zuang, V. (2003). ECVAM's response to the changing political environment for alternatives: Consequences of the European Union Chemicals and Cosmetics Policies. Altern. Lab. Anim. 31, 473-481.

37 Saldanha, J. (1999). Standardisation: a progress report. Biologicals 27, 285-289.

38 Seagroatt, V. and Kirkwood, T. B. (1986). Principles of biological standardisation and the conduct of collaborative studies to establish international standards. Lymphokine Res. 5 (suppl.), S7-S11.

39 World Health Organization Expert Committee on Biological Standardization (1990) Guidelines for the preparation characterisation and establishment of international and other standards and reference reagents for biological substances. WHO Technical Report Series, No. 800, World Health Organization, Geneva, Switzerland. N. B. This document was reviewed in 2004; details may be obtained through WHO and at

40 Fleck, R. A., Athwal, H., Bygraves, J. A., Hockley, D., Feavers, I. M., and Stacey, G. N. (2003). Optimisation of NB-4 and HL-60 differentiation for use in oposonophagocytosis assays. In Vitro Cell Dev. Biol. Anim. 39, 235-242.

41 Battle, T., Maguire, T., Moulsdale, H., and Doyle, A. (1999). Progressive maturation resistance to microcystin-LR cytotoxicity in two different hepatospheroidal models. Cell Biol. Toxicol. 15, 3-12.

42 Li, N., Tourovskaia, A., and Folch, A. (2003). Biology on a chip: microfabrication for studying the behavior of cultured cells. Crit. Rev. Biomed. Eng. 31, 423-488.

43 Park, T. H. and Shuler, M. L. (2003). Integration of cell culture and microfabrication technology. Biotechnol. Prog. 19, 243-253.

44 Sniadecki, N. J., Desai, R. A., Ruiz, S. A., and Chen, C. S. (2006). Nanotechnology for cell-substrate interactions. Ann. Biomed. Eng., March 9, 2006; [E-pub ahead of print]

45 Spielmann, H., Pohl, I., Doering, B., Liebsch, M., and Moldenhauer, F. (1997). The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicol. 10, 119-127.

46 Buesen, R., Visan, A., Genschow, E., Slawik, B., Spielmann, H., and Seiler, A. (2004). Trends in improving the embryonic stem cell test (EST): an overview. ALTEX 21, 15-22.

47 Bremer, S. and Bigot, K.(1997). Comparison of three different toxicological end points in the establishment of an in vitro embryotoxicity screening system based on embryonic stem cells. Eur. J. Cell Biol. 74, 26.

48 Scholz, G., Pohl, I., Genschow, E., Klemm, M., and Spielmann, H. (1999). Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 165, 203-211.

49 Rolletschek, A., Blyszczuk, P., and Wobus, A. M. (2005). Embryonic stem cell-derived cardiac, neuronal and pancreatic cells as model systems to study toxicological effects. Physiol. Rev. 85, 635-678.

50 Bremer, S. and Hartung, T. (2004). The use of embryonic stem cells for regulatory developmental toxicity testing in vitro - the current status of test development. Curr. Pharm. Design 10, 2733-2747.

51 Van Leeuwen, C. J., Grootelaar, E. M., and Niebeek, G. (1990).

Fish embryos as teratogenicity screens: a comparison of embryotoxicity between fish and birds. Ecotoxicol. Environ. Safety 20, 42-52.

52 Nagel, R. (2002). DarT: The embryo test with the zebrafish Danio rerio - a general model in ecotoxicology and toxicology. ALTEX 19, 38-48.

53 Pickering, S. J., Minger, S. L., Patel, M., Taylor, H., Black, C., Burns, C. J., Ekonomou, A., and Braude, P. R. (2005). Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis. Reprod. Biomed. Online 10, 390-397.

54 Andrews, P. W., Benvenisty, N., McKay, R., Pera, M. F., Rossant, J., Semb, H., and Stacey, G. N. (2005). The International Stem Cell Initiative: toward bench marks for human embryonic stem cell research. Nat. Biotechnol. 23, 795-797.

55 Loring, J. F. and Rao, M. S. (2006). Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells 24, 145-150.

56 Anderson, R., Balls, M., Burke, D., Cummins, M., Fehily, D., Gray, N., de Groot, M. G., Helin, H., Hunt, C., Jones, D., Price, D., Richert, L., Ravid, R., Shute, D., Sladowski, D., Stone, H., Thasler, W., Trafford, J., van der Valk, J., Weiss, T., Womack, C., and Ylikomi, T. (1998). The Establishment of Human Research Tissue Banking in the UK and Several Western European Countries; The Report and Recommendations of ECVAM Workshop 44. Alt. Lab. Anim. 29, 125-134.

57 Patterson, M. K. (1979). Measurement of growth and viability of cells in culture. Methods Enzymol. 58, 141-152.

58 Freshney J. (1994). A Culture of Animal Cells. 3rd edition, Wiley Liss Inc., New York.

59 Stacey, A. and Stacey, G. N. (2000). Routine quality control testing of cell cultures: Dectection of Mycoplasma. In: Kinchington, D. and Schinazi, R. F. (Eds.), Antiviral Methods and Protocols. Humana Press, Totowa, IL, pp. 27-40.

60 Stacey, G. N. (2001). Detection of Mycoplasma by DNA amplification (PCR). In: Doyle, A., Griffiths, J. B. (Eds.), Cell and Tissue Culture for Medical Research. Wiley, Chichester, Chap. 2, pp. 58-61.

0 0

Post a comment